More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$48.82B
EPS
6.11
P/E ratio
48.4
Price to sales
13.86
Dividend yield
--
Beta
0.895974
Previous close
$302.42
Today's open
$305.36
Day's range
$299.36 - $305.36
52 week range
$148.05 - $325.99
show more
CEO
Peter P. Gassner
Employees
7928
Headquarters
Pleasanton, CA
Exchange
New York Stock Exchange
Shares outstanding
161908850
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Veeva to Release Fiscal 2027 Third Quarter Results on December 3, 2026
PLEASANTON, Calif., Nov. 12, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter ending October 31, 2026 after market close on December 3, 2026.
PRNewsWire • Nov 12, 2026

Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Veeva (VEEV). This makes it worthwhile to examine what the stock has in store.
Zacks Investment Research • Nov 12, 2026

The Post-Midterm Rally Clock Is Ticking—and These 3 AI Stocks Stand Out
Stocks rallied on Nov. 4, following the midterm elections, but the gains disappeared the next session. On Nov. 5, the S&P 500 fell about 4.4% and the Nasdaq-100 roughly 6.3%, while the Cboe Volatility Index (VIX) jumped above 25.
MarketBeat • Nov 12, 2026

AMG TimesSquare Mid Cap Growth Fund Q3 2026 Portfolio Update
During this quarter, AMG TimesSquare Mid Cap Growth Fund performed in line with the Russell Midcap® Growth Index. Our leading contributors were software and health care technology companies that exceeded expectations for the fiscal quarter, with each pointing to AI as an expanding source of demand. Our overweight in Industrials, one of the benchmark's weakest sectors, also weighed on allocation.
Seeking Alpha • Nov 11, 2026

Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
VEEV's strong Q2 results, expanding Vault CRM adoption and diversified product portfolio support growth prospects, though market saturation poses risks.
Zacks Investment Research • Nov 10, 2026

Veeva Systems Inc. (VEEV) Analyst/Investor Day Transcript
Veeva Systems Inc. (VEEV) Analyst/Investor Day Transcript
Seeking Alpha • Nov 7, 2026

Veeva Systems Sticks to $6 Billion Revenue Goal as AI Expands Its Market Opportunity
Veeva Systems NYSE: VEEV said it remains on track to reach a $6 billion revenue run rate by calendar 2030, as the life sciences software provider expands its artificial intelligence offerings and pursues more business from clinical research organizations.
MarketBeat • Nov 6, 2026

OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Veeva Systems (VEEV). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Nov 5, 2026

UCB Selects Veeva Vault CRM
Agentic CRM platform to drive unified engagement worldwide PLEASANTON, Calif., Nov. 4, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that UCB has committed to Veeva Vault CRM, the agentic engagement platform for life sciences.
PRNewsWire • Nov 4, 2026

Veeva Systems: AI Is The Icing, Not The Cake
Veeva Systems earns a buy rating as core business growth re-accelerates, with AI-driven upside from Falcon agents not yet priced in. Commercial Solutions segment re-accelerated to 13% YoY subscription growth; R&D and Quality remain robust at 19.3% YoY, both supporting the investment thesis. Major tailwinds include CRM migration from Salesforce, early-stage AI adoption, and resilient end-markets in highly regulated life sciences.
Seeking Alpha • Nov 3, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Veeva Systems Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.